Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 249.50
Bid: 250.00
Ask: 251.00
Change: -5.00 (-1.96%)
Spread: 1.00 (0.40%)
Open: 260.00
High: 260.00
Low: 249.00
Prev. Close: 254.50
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio management: Spire Tunbridge Wells

3 Apr 2024 07:00

RNS Number : 0558J
Spire Healthcare Group PLC
03 April 2024
 

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Company' or 'the Group')

 

Portfolio management: Spire Tunbridge Wells Hospital

 

3 April 2024

 

Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, announces the sale of one of its leasehold hospitals, Spire Tunbridge Wells, to the Maidstone and Tunbridge Wells NHS Trust ('the Trust'), a major acute hospital trust in the south-east of England. The transaction includes the sale of the business and assets of Spire Tunbridge Wells. The consideration was £9.975m. The sale was completed on 31 March 2024.

 

Spire Healthcare remains committed to growth and takes a consistent and proactive approach to portfolio management. Following the transaction, the Group operates 38 hospitals (19 freehold and 19 leasehold properties). This transaction reflects Spire Healthcare's continued focus on disciplined capital allocation and meeting its stated ROCE targets.

 

Following completion of the transaction for a period expected to be around six months, Spire Healthcare will manage the hospital operations on behalf of the Trust continuing to provide treatment to both private and NHS patients.

 

Spire Tunbridge Wells is rated Good by the CQC, comprising 28 beds, 10 consulting rooms, 2 operating theatres and an endoscopy suite. Approximately 130 consultants operate from the hospital. For the year ended 31 December 2023, the hospital generated revenue of £12.7m and EBITDA of £1.1m. Leasehold rent incurred during the period was £0.4m and net cash generation (excluding working capital movements) was £0.7m. Capital expenditure during the year was £0.4m.

 

- Ends -

 

For further information please contact:

 

Spire Healthcare

Angus Prentice - Director of Investor Relations

 

+44 (0)7974 982 512

 

Instinctif Partners

Damian Reece

Guy Scarborough

 

+44 (0)7931 598 593

+44 (0)7917 178 920

 

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

 

About Spire Healthcare

 

Spire Healthcare is a leading independent healthcare group in the United Kingdom, with 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients.

 

Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over one million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services.

 

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good,' 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

 

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSSMFAEELSESL
Date   Source Headline
27th May 20211:30 pmRNSForm 8.3 - Spire Healthcare Group plc
27th May 20211:12 pmRNSForm 8.3 - Spire Healthcare Group Plc
27th May 20211:04 pmRNSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
27th May 202111:19 amRNSForm 8.3 - Spire Healthcare Group plc
27th May 202110:31 amRNSForm 8.5 (EPT/RI) - Spire Healthcare Group plc
27th May 202110:09 amRNSForm 8.5 (EPT/RI)-Spire Healthcare Group plc
27th May 20219:53 amRNSForm 8.5 (EPT/RI)
27th May 20219:43 amPRNForm 8.3 - Spire Healthcare Group Plc
27th May 20219:07 amBUSForm 8.3 - SPIRE HEALTHCARE GROUP PLC
26th May 20214:00 pmPRNForm 8.3 - Spire Healthcare Group plc
26th May 20213:28 pmRNSForm 8.3 - Spire Healthcare Group Plc
26th May 202112:47 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
26th May 20217:22 amRNSRecommended Offer for Spire Healthcare Group plc
13th May 20214:42 pmRNSChanges to committee memberships
13th May 20214:28 pmRNSResult of AGM
13th May 20217:00 amRNSAGM STATEMENT
4th May 202110:50 amRNSTotal Voting Rights
21st Apr 20218:48 amRNSHolding(s) in Company
6th Apr 20212:22 pmRNS2020 Annual Report and 2021 Notice of AGM
1st Apr 202111:28 amRNSTotal Voting Rights
19th Mar 20214:36 pmRNSReplacement - Director/PDMR Shareholding
18th Mar 20213:31 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSDirectorate announcement
4th Mar 20217:00 amRNSFinal Results
1st Feb 20212:27 pmRNSTotal Voting Rights
7th Jan 202110:55 amRNSBlock listing application
22nd Dec 20204:45 pmRNSDirector Declaration
21st Dec 20202:42 pmRNSNHS England contract update and trading update
8th Dec 20202:15 pmRNSNHS England contract update
17th Sep 20207:00 amRNSDirectorate announcement
17th Sep 20207:00 amRNSHalf-year Report
13th Aug 20207:00 amRNSNHS contract variation and trading update
1st Jul 20207:10 amRNSCMA investigation concluded
26th Jun 20209:30 amRNSAppointment of Professor Clifford Shearman
14th May 20202:04 pmRNSmembership of Nomination Committee
14th May 202012:51 pmRNSResult of AGM
14th May 20207:00 amRNSAGM Statement
27th Apr 20204:40 pmRNSHolding(s) in Company
9th Apr 20204:05 pmRNSAgreement signed with the NHS Scotland
8th Apr 20203:44 pmRNSHolding(s) in Company
6th Apr 20204:45 pmRNSDirector/PDMR Shareholding
6th Apr 20202:33 pmRNSAnnual Report and Notice of Annual General Meeting
6th Apr 20201:08 pmRNSHeads of Terms signed with the NHS in Wales
6th Apr 20209:00 amRNSDirector/PDMR Shareholding
1st Apr 20207:00 amRNSCovenant waiver agreed with lenders
23rd Mar 20207:00 amRNSStatement re Agreement with NHS England
19th Mar 20204:21 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSNext steps on NHS response to COVID-19
13th Mar 20207:00 amRNSNHS COVID-19 support
5th Mar 20207:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.